Skip to main content

Table 1 Demographic and clinical findings of the study patients

From: Predicting the outcome in confirmed COVID-19 patients with coronary artery disease: a key role for the first chest computed tomography

  Total (n=48)
Age, mean 60.8±13.2
Male 36 (75)
Underlying cardiac disease  
 History of CABG 24
 History of PCI 12
 History of positive coronary angiography/CT angiography 12
  Three vessel disease 1
  Two vessel disease 1
  Mild CAD* 10
 Concomitant valvular heart disease 5
Symptoms  
 Chest pain 24 (50)
 Dyspnea 23 (47.9)
 Fever 12 (25)
 Coughing 12 (25)
 Muscle pain 4 (8.3)
 Fatigue 5 (10.4)
Symptom onset to chest CT 3 days
 Percentile 25th, 75th 1, 4 days
 Range 0–9 days
Risk factors and comorbidities  
 Diabetes mellitus 22 (45.8)
 Hypertension 32 (66.7)
 cigarette smoking 16 (33.3)
 Dyslipidemia 23 (47.9)
 Opium addiction 8 (16.7)
 COPD 1 (2.1)
 Renal failure 5 (10.4)
 LVEF ≤35% 11 (22.9)
Drug history  
 Insulin 6 (12.8)
 Oral DM drugs 7 (14.9)
 Statin 28 (60.9)
 ARB/ACEI 26 (54.2)
  1. CT, computed tomography; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; LVEF, left ventricular ejection fraction; ARB, angiotensin II receptor blocker; ACEI, angiotensin-converting-enzyme inhibitor
  2. *Mild coronary artery disease refers to 25–50% luminal stenosis in at least one of the major epicedial arteries